Bird Flu (H5N1 Avian Influenza) Vaccine Blogs This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Better Health Care Tests, Faster
This article looks at some specific problems and solutions. Speeding up Test Development We’ve seen with COVID-19 how quickly a virus can evolve and how hard it is to design both tests and vaccinations that accommodate different variants. Virax Biolabs uses data from the World Health Organization and others to develop tests quickly. For instance, new viral variants tend to spread in the southern hemisphere before hitting the northern hemisphere in our Winter, so Virax can check existing data to prepare better tests for the North. The company is developing a T-cell diagnostics and profiling platform called Virax Immu...
Source: EMR and HIPAA - June 13, 2023 Category: Information Technology Authors: Andy Oram Tags: Health IT Company Healthcare IT Hospital - Health System Interoperability CLIA COVID-19 Hydreight Immunexpress ixlayer Laboratories Labs Rolland Carlson Sepsis Sepsis Lab Tests Septicyte Shane Madden testing Tomasz George Source Type: blogs

H5N1 – It ’ s All About the Transmission
by Gertrud U. Rey Recent news headlines have been highlighting the global spread of H5N1, the strain of influenza virus that is typically associated with “bird flu.” This outbreak is the largest in recorded history, involving at least 50 million dead birds and countless non-human mammals, including sea lions, otters, mink, foxes, cats, dogs, and […] (Source: virology blog)
Source: virology blog - March 2, 2023 Category: Virology Authors: Gertrud U. Rey Tags: Basic virology Gertrud Rey avian influenza H5N1 bird flu human-to-human transmission lower respiratory tract pandemic sialic acid upper respiratory tract vaccine Source Type: blogs

Avian influenza, bird flu, H5N1
A bird flu pandemic has killed thousands of wild birds over the last couple of years. Scientists have now seen infection in mammals, and very recently a person died from avian influenza and several close contacts show signs of infection. The concern is that we might be headed for another H5N1 pandemic. Previous strains of H5N1 that infected people had a mortality rate of 60 percent. Avian influenza, bird flu, H5N1 There are fifteen known variants of avian influenza. The most virulent, and usually fatal in birds, are the H5 and H7 strains. There are then nine variants of the H5 strain and the type of most concern because ...
Source: David Bradley Sciencebase - Songs, Snaps, Science - February 27, 2023 Category: Science Authors: David Bradley Tags: Bird Flu Health and Medicine Vaccines Source Type: blogs

The Social Science of Covid
By MIKE MAGEE As we enter the third year of the Covid pandemic, with perhaps a partial end in sight, the weight of the debate shows signs of shifting away from genetically engineered therapies, and toward a social science search for historic context. Renowned historian, Charles E. Rosenberg, envisioned a similar transition for the AIDS epidemic in 1989. He described its likely future course then as a “social phenomenon” with these words, “Epidemics start at a moment in time, proceed on a stage limited in space and duration, follow a plot line of increasing and revelatory tension, move to a crisis of individual ...
Source: The Health Care Blog - January 31, 2022 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Health Policy COVID-19 COVID-19 vaccine Mike Magee vaccines Source Type: blogs

Fight Aging! Newsletter, January 3rd 2022
In this study, we showed that the iPaD (inducing Plagl2 and anti-Dyrk1a) lentivirus substantially rejuvenated the proliferative and neurogenic potential of NSCs in the aged brain. Clonal analysis by a sparse labeling approach as well as transcriptome analysis indicated that iPaD can rejuvenate aged NSCs (19-21 mo of age) to a level comparable with those at 1 or 2 months of age and successfully improved cognition of aged mice. Once rejuvenated and activated by iPaD, aged dormant NSCs can generate, on average, 4.9 neurons but very few astrocytes in 3-week tracing. Furthermore, these activated NSCs were maintained for ...
Source: Fight Aging! - January 2, 2022 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Towards More Broadly Effective Influenza Vaccines
Might it be possible to develop a vaccine that works on every strain of influenza, rather than going through a seasonal exercise of vaccination every year? Or at least many strains, rather than just a few? In today's research materials, scientists discuss a possible approach, identifying a novel part of the influenza virus to target, a part of the viral structure that may mutate less readily than the usual vaccine targets. Viruses mutate aggressively when they infect large population, a challenge to both vaccination and natural immunity. The immune system recognizes small parts of a virus, epitopes, and the epitopes most r...
Source: Fight Aging! - December 30, 2021 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs

Omicron (B.1.1529 COVID variant )
Last updated 1430 UK time 24th December 2021. Items added that day flagged NEW.Research literature and scientific informationPubMedLess sensitive strategy (finds 100 items as of 21st December - found 28 on 13th)More sensitive strategy - same as strategy above but have added Omicron lineages, BA.1 and BA.2(finds 140 items as of 21st December - found 67 on 13th. Note: results include work on any aspect of COVID from UK postcodes BA1 and BA2).PubMed COVID-19 Clinical Query Select aspect (diagnosis, treatment, etc.) from the drop down boxPreprintsCOVID preprints from medRxiv and bioRxiv (sorted...
Source: Browsing - November 27, 2021 Category: Databases & Libraries Tags: coronavirus COVID-19 Source Type: blogs

What a Year! | Pandemic Teaching & More | A Reflection | TAPP 86
Discussions that matter. In our private space, we can have the vulnerability needed for authentic, deep discussions. Discussions not limited to a sentence or two at a time.No ads. No spam. No fake news. No thoughtless re-shares. Just plain old connection with others who do what you do!Privacy. The A&P Professor community has the connectivity of Facebook and Twitter, but the security of a private membership site. None of your information can be shared outside the community, so you can share what you like without it being re-shared to the world. Like your dean, for instance. In our community, you can share your frustrati...
Source: The A and P Professor - January 27, 2021 Category: Physiology Authors: Kevin Patton Source Type: blogs

Research Provides No Basis for Pandemic Travel Bans
CONCLUSIONThe pre ‐COVID‐19 research is unanimous that governments cannot expect to rely on travel restrictions to prevent the spread of pandemics similar to influenza. Travel restrictions do not prevent the spread of disease and may only delay it for a few days or weeks if implemented prior to the interna tional transmission of the disease. The Trump administration’s travel restrictions waited until after the virus had already entered the United States, and they exempted many travelers from China, not to mention the rest of the world.[30]The research shows that the Trump administration should have known that ...
Source: Cato-at-liberty - April 15, 2020 Category: American Health Authors: David J. Bier Source Type: blogs

This treatment could save your life – COVID-19 and Convalescent Plasma Therapy
Ajay Kohli Vinay Kohli Chitra Chhabra Kohli By CHITRA CHHABRA KOHLI MD, AJAY KOHLI MD, and VINAY KOHLI MD, MBA With a doubling time of cases estimated between 3 days within the U.S. and about 6 days globally (at the time of this writing) COVID-19 is demonstrating its terrifying virulence as it spreads across the world. What’s perhaps equally terrifying, if not more, is the absence of a known cure or treatment plan for COVID-19. While there has been a lot of attention focused on Hydroxychloroquine and Azithromycin, there has been debate on the scientific validity of these treatment options, either as thera...
Source: The Health Care Blog - March 30, 2020 Category: Consumer Health News Authors: Christina Liu Tags: COVID-19 Patients Physicians Ajay Kohli Azithromycin convalescent plasma therapy coronavirus COVID-19 treatment hydroxychloroquine Pandemic Vinay Kohli Source Type: blogs

Ebola, forgotten but not gone
The recent WHO decision to declare the novel coronavirus outbreak a Public Health Emergency of International Concern (PHEIC), while both appropriate and hardly surprising, offers the opportunity to reflect on the previous PHEIC which was declared, namely the Ebola epidemic in Kivu region, Democratic Republic of the Congo (DRC). And you should really say the ongoing Ebola epidemic, as during the time since the declaration in July 2019 through to the present day (March 2020), a total of 3,453 cases have been reported [1]. The nCoV-2019 outbreak is still ballooning; as of today, over 400,000 confirmed cases worldwide with no ...
Source: GIDEON blog - March 25, 2020 Category: Databases & Libraries Authors: Kristina Symes Tags: Ebooks Epidemiology Outbreaks Source Type: blogs

Schizophrenia Prevalence: Fear-Mongering, Fake News & the NIMH
It’s odd what upsets some people. Take E. Fuller Torrey and Elizabeth Sinclair’s recent take on a change in the way a single number — the 12-month prevalence rate of schizophrenia — is displayed on the National Institute of Mental Health’s (NIMH) website. This esoteric number has little impact in most people’s lives. If you live with schizophrenia or know someone who does, they most likely don’t give a hoot about it. Like most people, they probably don’t even know what it means. But these two authors do care, suggesting the number was reduced due to a hypothesized renewed foc...
Source: World of Psychology - February 1, 2018 Category: Psychiatry & Psychology Authors: John M. Grohol, Psy.D. Tags: General Policy and Advocacy Psychiatry Psychology Research E Fuller Torrey incidence rates of schizophrenia Prevalence Rates prevalence rates of schizophrenia schizophrenia prevalence Treatment Advocacy Center Source Type: blogs

Public Health Funding And OMB Director Mulvaney ’s “Taxpayer First” Test
The first formal budget of the Trump era—billed as a “Taxpayer First” budget—contains some very bad news when it comes to the health of the American public. It proposes dramatic cuts in federal investments that keep us healthy and protected from harm, including a $1.2 billion cut from the budget for the Centers for Disease Control and Prevention (CDC). This is on top of the catastrophic cuts that will occur with the loss of the Prevention and Public Health Fund if the Affordable Care Act is repealed. It is the opposite of both what American taxpayers have asked for and what is owed to them. Office of Management and...
Source: Health Affairs Blog - June 8, 2017 Category: Health Management Authors: Edward L. Hunter Tags: Costs and Spending Featured GrantWatch Public Health Centers for Disease Control and Prevention Chronic Care Consumers Effectiveness Health Philanthropy Health Promotion and Disease PreventionGW vaccines Source Type: blogs

Student Researcher Finds New Clues About Flu with Old Data
Do you like to find new uses for old things? Like weaving old shirts into a rug, repurposing bottles into candle holders or turning packing crates into tables? Katie Gostic, a University of California, Los Angeles (UCLA) graduate student, likes finding new uses for old data. She channeled this interest when she analyzed existing data to study whether childhood exposure to flu affects a person’s future immunity to the disease. Gostic conducted research for the flu project during the summer of 2015 when she was visiting her boyfriend, a tropical biologist, in Alamos, Sonora, Mexico. Credit: Charlie de la Rosa. As an und...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - February 21, 2017 Category: Research Authors: Roya Kalantari Tags: Being a Scientist Computers in Biology Big Data Infectious Diseases Training Source Type: blogs